Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Tarsus Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Trevejo Jose M. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 1,604 shares
@ $18, valued at
$28.9k
|
|
| 08/25/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 8,000 shares
@ $17.23, valued at
$137.8k
|
|
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 9,000 shares
@ $18.58, valued at
$167.2k
|
|
| 06/12/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 3,100 shares
@ $20.01, valued at
$62k
|
|
| 06/12/2023 |
4
| Mottiwala Aziz (Chief Commercial Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 100 shares
@ $20, valued at
$2k
|
|
| 06/08/2023 |
4
| Mottiwala Aziz (Chief Commercial Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 2,143 shares
@ $18.61, valued at
$39.9k
Sold 2,500 shares
@ $19.34, valued at
$48.4k
|
|
| 05/19/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 8,000 shares
@ $15.9, valued at
$127.2k
|
|
| 05/15/2023 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Disposed of 215,576 shares
@ $0
Acquired 41,219 shares
@ $0 |
|
| 05/12/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 9,000 shares
@ $16.8, valued at
$151.2k
|
|
| 05/02/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 4,278 shares
@ $15.13, valued at
$64.7k
Sold 5,841 shares
@ $15.1, valued at
$88.2k
|
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2023 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 326 shares
@ $12.89, valued at
$4.2k
Sold 332 shares
@ $12.64, valued at
$4.2k
Sold 346 shares
@ $12.15, valued at
$4.2k
|
|
| 03/23/2023 |
4
| Trevejo Jose M. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 519 shares
@ $12.89, valued at
$6.7k
Sold 529 shares
@ $12.64, valued at
$6.7k
Sold 465 shares
@ $12.15, valued at
$5.6k
|
|
| 03/23/2023 |
4
| Neervannan Seshadri (COO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 372 shares
@ $12.89, valued at
$4.8k
Sold 379 shares
@ $12.64, valued at
$4.8k
Sold 390 shares
@ $12.15, valued at
$4.7k
|
|
| 03/23/2023 |
4
| Wahl Bryan (General Counsel) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 350 shares
@ $12.89, valued at
$4.5k
Sold 357 shares
@ $12.64, valued at
$4.5k
Sold 371 shares
@ $12.15, valued at
$4.5k
|
|
| 03/23/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 679 shares
@ $12.89, valued at
$8.8k
Sold 709 shares
@ $12.64, valued at
$9k
Sold 737 shares
@ $12.15, valued at
$9k
|
|
| 03/23/2023 |
4
| Whitfield Dianne C. (Chief Human Resources Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 326 shares
@ $12.89, valued at
$4.2k
Sold 333 shares
@ $12.64, valued at
$4.2k
Sold 345 shares
@ $12.15, valued at
$4.2k
|
|
| 03/23/2023 |
4
| Mottiwala Aziz (Chief Commercial Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 349 shares
@ $12.89, valued at
$4.5k
Sold 357 shares
@ $12.64, valued at
$4.5k
Sold 372 shares
@ $12.15, valued at
$4.5k
|
|
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Trevejo Jose M. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 504 shares
@ $13.28, valued at
$6.7k
Sold 530 shares
@ $12.61, valued at
$6.7k
|
|
| 03/21/2023 |
4
| Mottiwala Aziz (Chief Commercial Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 339 shares
@ $13.28, valued at
$4.5k
Sold 358 shares
@ $12.61, valued at
$4.5k
|
|
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 316 shares
@ $13.28, valued at
$4.2k
Sold 333 shares
@ $12.61, valued at
$4.2k
|
|
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Disposed of 215,575 shares
@ $0
Acquired 52,194 shares
@ $0 |
|
|
|
|